... it's not a competition, the compliant/successful are analyzed separately, and while we're at it, perhaps we can do away with this notion that any single outcome or cluster of outcomes is somehow more important because we've designated them as "primary" ahead of time.
Such is where I find my thoughts wandering as the Look AHEAD diabetes trial passes in and out of my head as I absorb the discussions of it here and about the web.
